Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Precursor Cell Lymphoblastic Leukemia-Lymphoma × regorafenib × 30 days × Clear all

Sponsor

Conditions

Colorectal Neoplasms 5 Sarcoma 2 Esophageal Neoplasms 2 Carcinoma, Hepatocellular 2 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Malignant Tumors 1 Small Cell Lung Carcinoma 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Liver Metastasis Colon Cancer 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Central Nervous System Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Squamous Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Merkel Cell 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Cyclophosphamide 19 fludarabine 14 fludarabine phosphate 10 Vincristine 10 Methotrexate 9 venetoclax 8 Melphalan 8 Granulocyte Colony-Stimulating Factor 8 Filgrastim 8 blinatumomab 7 Whole-Body Irradiation 7 Dexamethasone 7 Cytarabine 7 Stem Cell Transplantation 6 Magnetic Resonance Spectroscopy 6 Mycophenolic Acid 5 Mesna 5 Doxorubicin 5 Calcium Dobesilate 5 ponatinib 4 merphos 4 dexamethasone acetate 4 dexamethasone 21-phosphate 4 calaspargase pegol 4 Thiotepa 4 Tacrolimus 4 Specimen Handling 4 Rituximab 4 Prednisone 4 Peripheral Blood Stem Cell Transplantation 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡